Intellia Therapeutics NTLA Increase Decrease In Operating Right Of Use Assets
Increase Decrease In Operating Right Of Use Assets at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept ntla:IncreaseDecreaseInOperatingRightOfUseAssets.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's increase decrease in operating right of use assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Intellia Therapeutics's increase decrease in operating right of use assets?
- Intellia Therapeutics (NTLA) reported increase decrease in operating right of use assets of -$8.41M in Q1 2026.
- How has Intellia Therapeutics's increase decrease in operating right of use assets changed year-over-year?
- Intellia Therapeutics's increase decrease in operating right of use assets decreased by 16.5% year-over-year, from -$7.22M to -$8.41M.
- What is the long-term trend for Intellia Therapeutics's increase decrease in operating right of use assets?
- Over 4 years (2021 to 2025), Intellia Therapeutics's increase decrease in operating right of use assets has grown at a 37.2% compound annual growth rate (CAGR), from -$9.35M to -$33.09M.
- What does increase decrease in operating right of use assets mean?
- This reflects the net change in the balance sheet value of right-of-use assets arising from operating leases. It captures the impact of new lease acquisitions, modifications, or impairments on the company's asset base. Monitoring this helps investors understand the company's commitment to long-term facility or equipment usage through leasing arrangements.